Olga Toleva, MD, CCFP, FRCPC, MPH
Atlanta, GA, USA | @changeatheart
Staff Physician, Emory University
Atlanta, GA, USA | @changeatheart
CWHHA member since September 2021
Biography
Dr. Olga Toleva graduated Medicine in Sofia, Bulgaria and completed Family Medicine residency at the University of British Columbia, Vancouver, Canada. She subsequently practiced as a Family physician and after a year in practice entered the Internal Medicine residency program at UBC, Vancouver. Dr. Toleva completed her training in Adult Cardiology and Interventional cardiology at the University of Alberta, Edmonton, Canada. During her cardiology fellowship she also completed Masters in Public Health at The Harvard School of Public Health.
Dr. Toleva worked as an Assistant Professor in the University of Manitoba and an Interventional Cardiologist at St. Boniface Hospital from 2014 until March 2021. She was involved in Trans catheter Aortic Valve Replacement (TAVR) and coronary physiology. She focused on outcomes research, frailty and quality of life assessments in the older adults who are the predominant population requiring TAVR.
Dr. Olga Toleva just moved to the US and is a new Interventional Cardiologist at Emory Healthcare, primarily located at Emory St. Joseph’s Hospital. She is involved in Trans catheter Aortic Valve Replacement (TAVR) and coronary physiology microvascular dysfunction invasive testing in the cardiac catheterization laboratory. Dr. Toleva has a strong interest in Women's Heart Health with clinical work and research related to the diagnosis and therapy of Spontaneous Coronary Artery Dissection (SCAD), Myocardial infarction without obstructive coronary artery disease (MINOCA) and Micro Vascular Dysfunction (MVD) - chest pain syndromes without obstructive coronary disease. She will be part of the Emory Women’s Heart Health Clinic focusing on the care of patients and performing research in the area. These conditions are predominantly seen in women and continue to be poorly understood and under-treated. Dr. Toleva has a high volume PCI and TAVR practice and is very active in the world of coronary and structural heart research and innovation.
